日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Drug Development in Inflammatory Bowel Diseases: What Is Next?

炎症性肠病药物研发:下一步是什么?

Petronio, Lorenzo; Dal Buono, Arianna; Gabbiadini, Roberto; Migliorisi, Giulia; Privitera, Giuseppe; Ferraris, Matteo; Loy, Laura; Bezzio, Cristina; Armuzzi, Alessandro

Maternal AA/EPA Ratio and Triglycerides as Potential Biomarkers of Patients at Major Risk for Pharmacological Therapy in Gestational Diabetes

母体 AA/EPA 比率和甘油三酯作为妊娠期糖尿病药物治疗高风险患者的潜在生物标志物

Chiara Maria Soldavini, Gabriele Piuri, Gabriele Rossi, Paola Antonia Corsetto, Linda Benzoni, Valeria Maggi, Giulia Privitera, Angela Spadafranca, Angela Maria Rizzo, Enrico Ferrazzi

Methylglyoxal, Glycated Albumin, PAF, and TNF-α: Possible Inflammatory and Metabolic Biomarkers for Management of Gestational Diabetes

甲基乙二醛、糖化白蛋白、PAF 和 TNF-α:可用于治疗妊娠期糖尿病的可能的炎症和代谢生物标志物

Gabriele Piuri, Katia Basello, Gabriele Rossi, Chiara Maria Soldavini, Silvia Duiella, Giulia Privitera, Angela Spadafranca, Andrea Costanzi, Emiliana Tognon, Mattia Cappelletti, Paola Antonia Corsetto, Angela Maria Rizzo, Attilio Francesco Speciani, Enrico Ferrazzi

COVID-19 Emergency Management: From the Reorganization of the Endoscopy Service to the Verification of the Reprocessing Efficacy

新冠肺炎疫情应急管理:从内镜服务重组到再处理效果验证

Casini, Beatrice; Tuvo, Benedetta; Maggi, Fabrizio; Del Magro, Giuliana; Ribechini, Alessandro; Costa, Anna Laura; Totaro, Michele; Baggiani, Angelo; Gemignani, Giulia; Privitera, Gaetano